Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

• Peter Batar,
• Hussain Alizadeh,
• Gyorgy Rokszin,
• Zsolt Abonyi-Toth,
• Zsolt Abonyi-Toth,
• Judit Demeter

Affiliations

Peter Batar

Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

Hussain Alizadeh

1st Department of Medicine, Division of Haematology, Clinical Center, Medical School, University of Pecs, Pecs, Hungary

Gyorgy Rokszin

RxTarget Ltd., Szolnok, Hungary

Zsolt Abonyi-Toth

RxTarget Ltd., Szolnok, Hungary

Zsolt Abonyi-Toth

Department of Biostatistics, University of Veterinary Medicine, Budapest, Hungary

Judit Demeter

Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary